Prolor Reports Positive Results in Hemophilia Study

Link to Article The study found that the mice which received Factor VIIa-CTP showed a superior survival rate. Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH) today reported positive results in a comparative study of its longer-acting version of the hemophilia drug Factor VIIa, Factor VIIa-CTP drug, in a preclinical trial in mice. The study is […]

Developments in Clinical Use of Plasma Therapies

Link to WebsiteIPPC 2012 SPEAKERS TO ADDRESS DEVELOPMENTS IN CLINICAL USE OF PLASMA PROTEIN THERAPIESBRUSSELS, BELGIUM (February 14th, 2012) The International Plasma Protein Congress (IPPC) 2012 will take place on March 13-14 in Madrid, Spain at the Hotel Melia Princesa and will feature a panel of experts discussing their findings on the development of clinical […]